Status:
COMPLETED
Pretreatment Aceclofenac Effect on Pain and Analgesic Intake After Endodontic Treatment
Lead Sponsor:
Cairo University
Conditions:
Symptomatic Irreversible Pulpitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of this prospective, randomized, double-blind, clinical trial is to evaluate the effect of a preoperative, single, oral dose of aceclofenac (100 mg) on postendodontic pain at 6, 24 and 48 hour...
Detailed Description
* Patients will be clinically and radiographically examined and their eligibility will be assessed and preoperative pain will be measured using Heft-Parker VAS. Eligible patients will be treated in on...
Eligibility Criteria
Inclusion
- Patients in good health (American Society of Anesthesiologists Class I or Class II).
- Patients having symptomatic irreversible pulpitis in one of their mandibular molars
- Age is 18 years or older.
- Patients who can understand Heft- Parker Visual Analogue Scales.
- Patients able to sign informed consent.
Exclusion
- Patients allergic to aceclofenac or Mepivacaine.
- Pregnant or nursing women.
- Patients having active pain in more than one molar in the same quadrant.
- Administration of analgesics within 12 h before the administration of the study drug.
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03335007
Start Date
May 1 2015
End Date
July 1 2017
Last Update
November 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, 11553